Deals30 Dec 2025, 05:21 pm
Alkem Laboratories Ltd Completes Transfer of Trade Generics Business for Rs. 532.5 Crores
AI Summary
Alkem Laboratories Ltd has completed the transfer of its trade generics business to its wholly owned subsidiary, Alkem Wellness Limited, for a final sale consideration of Rs. 532.5 crores. This transfer was effected through a Business Transfer Agreement dated 26th September, 2025, and the balance sale consideration of Rs. 32.5 crores was paid by Alkem Wellness to Alkem Laboratories Ltd on 30th December, 2025. This information is available on the company's website.
Key Highlights
- Alkem Laboratories Ltd has completed the transfer of its trade generics business to Alkem Wellness Limited.
- The final sale consideration is Rs. 532.5 crores.
- The transfer was effected through a Business Transfer Agreement dated 26th September, 2025.
- Alkem Wellness paid the balance sale consideration of Rs. 32.5 crores on 30th December, 2025.
- The information is available on the company's website.